TWA
FSTX

TCI Wealth Advisors’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

TCI Wealth Advisors’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-300
Closed -$2K – 2700
2022
Q2 		$2K Hold
300
– – ﹤0.01% 2071
2022
Q1 		$1K Buy
300
+100
+50% +$369 ﹤0.01% 2187
2021
Q4 		$1K Buy
+200
New +$1.21K ﹤0.01% 2273

Other funds holding FSTX

RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DMKJ
David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TCI Wealth Advisors's FSTX Position: Q3 2022 in Review

TCI Wealth Advisors sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q3 2022, closing a stake of 300 shares — an estimated $2K sold.

TCI Wealth Advisors first reported a position in FSTX in Q4 2021 and held it in 3 quarters. The position peaked at $2K in Q2 2022. 54 funds tracked by Wall St. Rank hold FSTX as of Q3 2022.

  • TCI Wealth Advisors reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • TCI Wealth Advisors sold 300 F-star Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $2K.
  • TCI Wealth Advisors first reported a position in F-star Therapeutics, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
  • TCI Wealth Advisors's F-star Therapeutics, Inc. Common Stock position peaked at $2K in Q2 2022.
  • 54 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q3 2022.

Based on TCI Wealth Advisors's 13F filing for Q3 2022, filed 8 Nov 2022.